Structure Therapeutics Inc. is emerging in oral GLP-1 obesity drugs after Phase II success and rivals’ setbacks. Click here ...

Cogent Biosciences released quarterly earnings results that came in below consensus expectations on an earnings-per-share ...

Halozyme Therapeutics is entering a powerful earnings inflection. FY25 revenue grew 38% to $1.397 billion. Check out why I am bullish on HALO stock.

Natco Pharma Limited has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market generic Semaglutide Injection in India, with the ...

Pfizer Inc. today announced positive topline progression-free (PFS) survival results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in ...

The beginning of 2026 has been characterized by volatility in equities. Amidst this, the S&P 500 Index ($SPX) has remained sideways. While the technology sector dominated headlines last year, it might ...

For much of nutrition science history, trace minerals were discussed almost exclusively in the context of deficiency diseases. Iodine prevented goiter, iron prevented anemia, and zinc supported growth ...

The Science: Europa has been considered as a top contender for alien life for even longer than Enceladus, thanks to its massive under-ice liquid water oceans. It also displays water vapor plumes ...

Averaged 6,650,000,000 cubic feet per day in the fiscal fourth quarter ended Dec. 31, 2025, rising 10% year over year due to sustained producer activity. NGL transportation -- Achieved a record ...

Detailed price information for Serina Therapeutics Inc (SER-A) from The Globe and Mail including charting and trades.

The 2026 Forbes Healthcare Summit will convene the world's most influential leaders in healthcare, medicine and science.

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.